Nextmune

Many dogs, cats and horses present with skin problem. They can appear with symptoms like itch, papules, crusts, scaling, comedones, pigment changes, hairloss, dull coat or bad odour.  Also, the claws or hoves belong to the skin and may be affected (deformation of claws or hooves or loss of claws). In cases where skin problems are present the veterinarian will take an extensive patient history and make a thorough clinical investigation. This investigation usually includes special tests like hair combings, skin scrapings, hair pluckings, cytology, bacterial culture, fungal culture, blood tests or skin biopsies.

It is important to determine the primary reason for the skin and coat problem. This process will typically take at least two or more visits. The list of possible primary causes for the skin problem can be long (parasites, allergies, infections, endocrinopathies, metabolic disease, malnutrition/malabsorption, immune mediated disease, tumors, etc).

Nextmune offers a large range of well documented skin products which can help relief the symptoms

One common cause for recurrent skin infection is allergy, such as flea allergy, food induced allergy and/or atopic dermatitis.

Nextmune is the global #1 in allergy diagnostics and treatment with a complete offer from the latest technology in allergy testing, Next+ and NextEQ, to the only licensed immunotherapy in Europe, Artuvetrin® Therapy.

To help find the best elimination diet use the Next+ Food Reactivity Test. Once the clinical diagnosis of atopic dermatitis is made run a Next+ (dogs, cats) or NextEQ serum test or an intradermal test, Artuvetrin® Skin Test.

The Next + serum test will also show if there is an allergic response towards flea saliva and NextEQ serum test will uncover any allergic response to insects.

Identifying the responsible allergens is a fundamental step to implement environmental control measures and to pick the correct allergens for an allergen specific immunotherapy, Artuvetrin® Therapy.  Artuvetrin® Therapy is the only licensed immunotherapy in Europe and the best option for long-term treatment of atopic dermatitis.